Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2016
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein
Shenying Fang, Dawen Sui, Yuling Wang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 24, 2016
Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma
Jian Yu Xu, William A Murphy, Denái R Milton, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 19, 2025
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in <i>RET</i>-Mutant Medullary Thyroid Cancer
Rossella Elisei, Lori J Wirth, Jaume Capdevila, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer
Rozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd, et al.
Annals of Surgical Oncology
|
February 11, 2018
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma
Minerva A Romero Arenas, Thereasa A Rich, Samuel M Hyde, et al.
Head & Neck
|
September 2, 2025
Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer
Isabelle Fournier, Ashwini Venkata Bandi, Sarah Hamidi, et al.
Head & Neck
|
October 8, 2025
Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival
Anastasios Maniakas, David C Wilde, Isabelle Fournier, et al.
Head & Neck
|
November 27, 2023
Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer
Anastasios Maniakas, Andrew Sullivan, Mimi I Hu, et al.
The New England Journal of Medicine
|
October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer
Julien Hadoux, Rossella Elisei, Marcia S Brose, et al.
ESMO Open
|
October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Aparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2016
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein
Shenying Fang, Dawen Sui, Yuling Wang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 24, 2016
Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma
Jian Yu Xu, William A Murphy, Denái R Milton, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 19, 2025
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in <i>RET</i>-Mutant Medullary Thyroid Cancer
Rossella Elisei, Lori J Wirth, Jaume Capdevila, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer
Rozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd, et al.
Annals of Surgical Oncology
|
February 11, 2018
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma
Minerva A Romero Arenas, Thereasa A Rich, Samuel M Hyde, et al.
Head & Neck
|
September 2, 2025
Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer
Isabelle Fournier, Ashwini Venkata Bandi, Sarah Hamidi, et al.
Head & Neck
|
October 8, 2025
Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival
Anastasios Maniakas, David C Wilde, Isabelle Fournier, et al.
Head & Neck
|
November 27, 2023
Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer
Anastasios Maniakas, Andrew Sullivan, Mimi I Hu, et al.
The New England Journal of Medicine
|
October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer
Julien Hadoux, Rossella Elisei, Marcia S Brose, et al.
ESMO Open
|
October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Aparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
Page
of 10